FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080363965> ?p ?o ?g. }

• W2080363965 endingPage "670" @default.
• W2080363965 startingPage "665" @default.
• W2080363965 abstract "Objectives: To provide a global, up-to-date picture of the prevalence, treatment, and outcomes of Candida bloodstream infections in intensive care unit patients and compare Candida with bacterial bloodstream infection. Design: A retrospective analysis of the Extended Prevalence of Infection in the ICU Study (EPIC II). Demographic, physiological, infection-related and therapeutic data were collected. Patients were grouped as having Candida, Gram-positive, Gram-negative, and combined Candida/bacterial bloodstream infection. Outcome data were assessed at intensive care unit and hospital discharge. Setting: EPIC II included 1265 intensive care units in 76 countries. Patients: Patients in participating intensive care units on study day. Interventions: None. Measurement and Main Results: Of the 14,414 patients in EPIC II, 99 patients had Candida bloodstream infections for a prevalence of 6.9 per 1000 patients. Sixty-one patients had candidemia alone and 38 patients had combined bloodstream infections. Candida albicans (n = 70) was the predominant species. Primary therapy included monotherapy with fluconazole (n = 39), caspofungin (n = 16), and a polyene-based product (n = 12). Combination therapy was infrequently used (n = 10). Compared with patients with Gram-positive (n = 420) and Gram-negative (n = 264) bloodstream infections, patients with candidemia were more likely to have solid tumors (p < .05) and appeared to have been in an intensive care unit longer (14 days [range, 5–25 days], 8 days [range, 3–20 days], and 10 days [range, 2–23 days], respectively), but this difference was not statistically significant. Severity of illness and organ dysfunction scores were similar between groups. Patients with Candida bloodstream infections, compared with patients with Gram-positive and Gram-negative bloodstream infections, had the greatest crude intensive care unit mortality rates (42.6%, 25.3%, and 29.1%, respectively) and longer intensive care unit lengths of stay (median [interquartile range]) (33 days [18–44], 20 days [9–43], and 21 days [8–46], respectively); however, these differences were not statistically significant. Conclusion: Candidemia remains a significant problem in intensive care units patients. In the EPIC II population, Candida albicans was the most common organism and fluconazole remained the predominant antifungal agent used. Candida bloodstream infections are associated with high intensive care unit and hospital mortality rates and resource use." @default.
• W2080363965 created "2016-06-24" @default.
• W2080363965 creator A5003379719 @default.
• W2080363965 creator A5024122313 @default.
• W2080363965 creator A5076578951 @default.
• W2080363965 creator A5080813847 @default.
• W2080363965 date "2011-04-01" @default.
• W2080363965 modified "2023-10-18" @default.
• W2080363965 title "Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*" @default.
• W2080363965 cites W1898928487 @default.
• W2080363965 cites W1974342169 @default.
• W2080363965 cites W1987762500 @default.
• W2080363965 cites W1994613828 @default.
• W2080363965 cites W1995287041 @default.
• W2080363965 cites W2003661565 @default.
• W2080363965 cites W2012050459 @default.
• W2080363965 cites W2013666547 @default.
• W2080363965 cites W2035238837 @default.
• W2080363965 cites W2039181347 @default.
• W2080363965 cites W2041927838 @default.
• W2080363965 cites W2067245892 @default.
• W2080363965 cites W2075579211 @default.
• W2080363965 cites W2081823113 @default.
• W2080363965 cites W2083761635 @default.
• W2080363965 cites W2087561016 @default.
• W2080363965 cites W2089115810 @default.
• W2080363965 cites W2103392160 @default.
• W2080363965 cites W2114509444 @default.
• W2080363965 cites W2118236446 @default.
• W2080363965 cites W2121247465 @default.
• W2080363965 cites W2125789788 @default.
• W2080363965 cites W2126319933 @default.
• W2080363965 cites W2128707850 @default.
• W2080363965 cites W2131468549 @default.
• W2080363965 cites W2135486637 @default.
• W2080363965 cites W2137351193 @default.
• W2080363965 cites W2137575148 @default.
• W2080363965 cites W2139043187 @default.
• W2080363965 cites W2139728976 @default.
• W2080363965 cites W2144268684 @default.
• W2080363965 cites W2146558016 @default.
• W2080363965 cites W2150428940 @default.
• W2080363965 cites W2152091452 @default.
• W2080363965 cites W2157046988 @default.
• W2080363965 cites W2162221318 @default.
• W2080363965 cites W2162723036 @default.
• W2080363965 cites W2164001967 @default.
• W2080363965 cites W2165158988 @default.
• W2080363965 cites W2171155970 @default.
• W2080363965 cites W2583550038 @default.
• W2080363965 cites W4247943214 @default.
• W2080363965 doi "https://doi.org/10.1097/ccm.0b013e318206c1ca" @default.
• W2080363965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21169817" @default.
• W2080363965 hasPublicationYear "2011" @default.
• W2080363965 type Work @default.
• W2080363965 sameAs 2080363965 @default.
• W2080363965 citedByCount "321" @default.
• W2080363965 countsByYear W20803639652012 @default.
• W2080363965 countsByYear W20803639652013 @default.
• W2080363965 countsByYear W20803639652014 @default.
• W2080363965 countsByYear W20803639652015 @default.
• W2080363965 countsByYear W20803639652016 @default.
• W2080363965 countsByYear W20803639652017 @default.
• W2080363965 countsByYear W20803639652018 @default.
• W2080363965 countsByYear W20803639652019 @default.
• W2080363965 countsByYear W20803639652020 @default.
• W2080363965 countsByYear W20803639652021 @default.
• W2080363965 countsByYear W20803639652022 @default.
• W2080363965 countsByYear W20803639652023 @default.
• W2080363965 crossrefType "journal-article" @default.
• W2080363965 hasAuthorship W2080363965A5003379719 @default.
• W2080363965 hasAuthorship W2080363965A5024122313 @default.
• W2080363965 hasAuthorship W2080363965A5076578951 @default.
• W2080363965 hasAuthorship W2080363965A5080813847 @default.
• W2080363965 hasConcept C126322002 @default.
• W2080363965 hasConcept C16005928 @default.
• W2080363965 hasConcept C177713679 @default.
• W2080363965 hasConcept C2776376669 @default.
• W2080363965 hasConcept C2779548794 @default.
• W2080363965 hasConcept C2780402444 @default.
• W2080363965 hasConcept C2780651595 @default.
• W2080363965 hasConcept C2780917455 @default.
• W2080363965 hasConcept C2987404301 @default.
• W2080363965 hasConcept C3018946976 @default.
• W2080363965 hasConcept C71924100 @default.
• W2080363965 hasConcept C86803240 @default.
• W2080363965 hasConcept C89423630 @default.
• W2080363965 hasConceptScore W2080363965C126322002 @default.
• W2080363965 hasConceptScore W2080363965C16005928 @default.
• W2080363965 hasConceptScore W2080363965C177713679 @default.
• W2080363965 hasConceptScore W2080363965C2776376669 @default.
• W2080363965 hasConceptScore W2080363965C2779548794 @default.
• W2080363965 hasConceptScore W2080363965C2780402444 @default.
• W2080363965 hasConceptScore W2080363965C2780651595 @default.
• W2080363965 hasConceptScore W2080363965C2780917455 @default.
• W2080363965 hasConceptScore W2080363965C2987404301 @default.
• W2080363965 hasConceptScore W2080363965C3018946976 @default.
• W2080363965 hasConceptScore W2080363965C71924100 @default.

• next